Ablation Treatment for Atrial Fibrillation
Tracking Results of Ablations to Combat AF Registry Generation 2
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 10,000 (estimated)
- Sponsor
- AtriCure, Inc. · Industry
This trial is looking for patients scheduled for heart ablation. Participants will help gather information on the safety and effectiveness of certain medical devices used during the procedure.
You may be able to join if
- I have been scheduled for a cardiac ablation procedure
- I am willing to provide informed consent
- I am 18 years old or older
You may not be able to join if
- I have other medical or psychological conditions that affect my ability to consent or follow the trial rules
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation.
Loading trial locations…